Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-065836
Filing Date
2015-02-26
Accepted
2015-02-26 16:37:29
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d832888d10k.htm 10-K 1048625
2 EX--11 d832888dex11.htm EX-11 26428
3 EX-21 d832888dex21.htm EX-21 1230
4 EX-23 d832888dex23.htm EX-23 2070
5 EX-31.1 d832888dex311.htm EX-31.1 9055
6 EX-31.2 d832888dex312.htm EX-31.2 9037
7 EX-32.1 d832888dex321.htm EX-32.1 3734
8 EX-32.2 d832888dex322.htm EX-32.2 3682
15 GRAPHIC g832888g08t96.jpg GRAPHIC 30661
  Complete submission text file 0001193125-15-065836.txt   8880598

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT qlti-20141231.xml EX-101.INS 1208836
10 XBRL TAXONOMY EXTENSION SCHEMA qlti-20141231.xsd EX-101.SCH 86571
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qlti-20141231_cal.xml EX-101.CAL 102805
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qlti-20141231_def.xml EX-101.DEF 279632
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE qlti-20141231_lab.xml EX-101.LAB 614126
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qlti-20141231_pre.xml EX-101.PRE 470523
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17082 | Film No.: 15653106
SIC: 2834 Pharmaceutical Preparations